HealthEquity Inc Cash Flow-to-Debt Ratio
HealthEquity Inc cash flow-to-debt ratio. HealthEquity Inc (HQY) has a Cash Flow-to-Debt Ratio of 0.09x as of January 2026, meaning its operating cash flow of $117.92 Million could theoretically repay 0% of its total liabilities ($1.32 Billion) in one year. Check HealthEquity Inc (HQY) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of HealthEquity Inc (2013–2026)
Cash flow-to-debt ratio of HealthEquity Inc from 2013 to 2026. Historical debt coverage capacity for HealthEquity Inc across 14 annual periods. Check HQY capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
HealthEquity Inc Cash Flow-to-Debt Ratio by Year (2013–2026)
HealthEquity Inc cash flow-to-debt ratio by year from 2013 to 2026. Year-by-year debt coverage analysis for HealthEquity Inc. For the full cash flow conversion analysis, see HealthEquity Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.35x | $457.09 Million | $1.32 Billion | ▲ +35.4% |
| 2025 | 0.25x | $339.86 Million | $1.33 Billion | ▲ +18.5% |
| 2024 | 0.22x | $242.83 Million | $1.13 Billion | ▲ +70.4% |
| 2023 | 0.13x | $150.65 Million | $1.19 Billion | ▲ +12.3% |
| 2022 | 0.11x | $141.00 Million | $1.25 Billion | ▼ -17.6% |
| 2021 | 0.14x | $181.62 Million | $1.33 Billion | ▲ +97.7% |
| 2020 | 0.07x | $105.86 Million | $1.53 Billion | ▼ -98.0% |
| 2019 | 3.44x | $113.42 Million | $32.94 Million | ▼ -3.5% |
| 2018 | 3.57x | $81.70 Million | $22.89 Million | ▲ +34.7% |
| 2017 | 2.65x | $45.59 Million | $17.20 Million | ▲ +63.2% |
| 2016 | 1.62x | $26.54 Million | $16.34 Million | ▲ +58.4% |
| 2015 | 1.03x | $15.05 Million | $14.67 Million | ▲ +20.0% |
| 2014 | 0.85x | $18.02 Million | $21.08 Million | ▼ -39.7% |
| 2013 | 1.42x | $11.77 Million | $8.30 Million | — |